Bio-Rad Laboratories, Inc. (BIO) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Bio-Rad Laboratories, Inc. (BIO) closed at USD 362.43 on 2026-10-14, a change of +9.7 % over the past year, with a market capitalization of USD 9.76B.
Bio-Rad Laboratories, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 362.43 |
| 2026-10-13 | 363.73 |
| 2026-10-12 | 364.42 |
| 2026-10-09 | 366.16 |
| 2026-10-08 | 360.40 |
| 2026-10-07 | 367.92 |
| 2026-10-06 | 368.83 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Bio-Rad Laboratories, Inc. key figures
- Previous close
- USD 362.43 (2026-10-14)
- 1-year change
- +9.7 %
- Market cap
- USD 9.76B
- Enterprise value
- USD 9.51B
- P/E ratio (trailing)
- 46.12
- P/E ratio (forward)
- 37.43
- EPS (trailing)
- 7.91
- EPS (forward)
- 9.75
- PEG ratio
- 4.01
- Price to book
- 1.36
- Revenue growth
- -0.1 %
- Earnings growth
- 18.7 %
- Dividend per share (trailing)
- 0.00
- Short ratio
- 4.37
- Employees
- 7,450
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Bio-Rad Laboratories, Inc. and compare it with other stocks.
Analyze BIOAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Bio-Rad Laboratories, Inc. shares.